Cargando…
Edaravone and cyclosporine A as neuroprotective agents for acute ischemic stroke
It is well known that acute ischemic stroke (AIS) and subsequent reperfusion produce lethal levels of reactive oxygen species (ROS) in neuronal cells, which are generated in mitochondria. Mitochondrial ROS production is a self‐amplifying process, termed “ROS‐induced ROS release”. Furthermore, the mi...
Autores principales: | Matsumoto, Shohei, Murozono, Michihiro, Kanazawa, Masahiro, Nara, Takeshi, Ozawa, Takuro, Watanabe, Yasuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028804/ https://www.ncbi.nlm.nih.gov/pubmed/29988669 http://dx.doi.org/10.1002/ams2.343 |
Ejemplares similares
-
A novel brain targeted plasma exosomes enhance the neuroprotective efficacy of edaravone in ischemic stroke
por: Guo, Lin, et al.
Publicado: (2021) -
How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
por: Watanabe, Kazutoshi, et al.
Publicado: (2018) -
Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
por: Shi, Fenghao, et al.
Publicado: (2022) -
New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments
por: Lapshina, Maria A., et al.
Publicado: (2023) -
Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
por: Qian, Yun, et al.
Publicado: (2019)